This article needs to be updated.(February 2015) |
A chronic electrode implant is an electronic device implanted chronically (for a long period) into the brain or other electrically excitable tissue. It may record electrical impulses in the brain or may stimulate neurons with electrical impulses from an external source.
The potential for neural interfacing technology to restore lost sensory or motor function is staggering; victims of paralysis due to peripheral nerve injury could achieve a full recovery by directly recording the output of their motor cortex, but the technology is immature and unreliable. There are numerous examples in the literature of intra-cortical electrode recording used to a variety of ends that fail after a few weeks, a few months at best. This document will review the current state of research into electrode failure, focusing on recording electrodes as opposed to stimulating electrodes.
Chronic brain-computer interfaces come in two varieties, stimulating and recording. Applications for stimulating interfaces include sensory prosthetics (cochlear implants), for example, are the most successful variety of sensory prosthetics) and deep brain stimulation therapies, while recording interfaces can be used for research applications and to record the activity of speech or motor centers directly from the brain. In principle these systems are susceptible to the same tissue response that causes failure in implanted electrodes, but stimulating interfaces can overcome this problem by increasing signal strength. Recording electrodes, however, must rely on whatever signals are present where they are implanted, and cannot easily be made more sensitive.
Current implantable microelectrodes are unable to record single- or multi-unit activity reliably on a chronic scale. Lebedev and Nicolelis discuss in their 2006 review the specific needs for research in the field to truly improve the technology to the level of clinical implementation. They suggest four directions for improvment:
This review will focus on techniques pursued in the literature that are relevant to achieving the goal of consistent, long-term recordings. Research towards this end can be divided into two primary categories: characterizing the specific causes of recording failure, and techniques for preventing or delaying electrode failure.
As mentioned above, if there is to be significant progress towards long-term implantable electrodes, an important step is documenting the response of living tissue to electrode implantation in both the acute and chronic timelines. It is ultimately this tissue response that causes electrodes to fail by encapsulating the electrode itself in a protective layer called a "glial scar", (see 2.2). One serious impediment to understanding the tissue response is the lack of true standardization of implantation technique or of electrode materials. Common materials for electrode or probe construction include silicon, platinum, iridium, polyimide, ceramic, gold, as well as others. In addition to the variety of materials used, electrodes are constructed in many different shapes, including planar shanks, simple uniform microwires, and probes that taper to a thin tip from a wider base. Implantable electrode research also employs many different techniques for surgically implanting the electrodes; the most critical differences are whether or not the implant is anchored across the skull and the speed of insertion. The overall observed tissue response is caused by a combination of the traumatic injury of electrode insertion and the persistent presence of a foreign body in the neural tissue.
Damage caused by electrodes in the short term is caused by the insertion into the tissue. Consequently, research into minimizing this is focused on the geometry of the electrode and the proper technique for insertion. Short term effects of electrode insertion on surrounding tissue have been documented extensively. They include cell death (both neuronal and glial), severed neuronal processes and blood vessels, mechanical tissue compression, and collection of debris resulting from cell death.
In the Bjornsson et al. 2006 study, an ex vivo apparatus was constructed explicitly to study the deformation of and damage to neural tissue during electrode insertion. Electrodes were constructed from silicon wafers to have three different sharpnesses (interior angle of 5° for sharp, 90° for medium, 150° for blunt). Insertion speed was also presented at three speeds, 2 mm/s, 0.5 mm/s, and 0.125 mm/s. Qualitative assessments of vascular damage were made by taking real-time images of electrodes being inserted into 500 um thick coronal brain slices. To facilitate direct visualization of vascular deformation, tissue was labeled with fluorescent dextran and microbeads before viewing. The fluorescent dextran filled the blood vessels, allowing initial geometry to be visualized along with any distortions or breakages. Fluorescent microbeads lodged throughout the tissue, providing discrete coordinates that aided in computerized calculations of strain and deformation. Analysis of the images prompted the division of tissue damage into 4 categories:
Fluid displacement by device insertion frequently resulted in ruptured vessels. Severing and dragging were consistently present along the insertion track, but did not correlate with tip geometry. Rather, these features were correlated with insertion speed, being more prevalent at medium and slow insertion speeds. Faster insertion of sharp probes was the only condition resulting in no reported vascular damage.
When implanted in neural tissue in the long term, microelectrodes stimulate a sort of foreign body response, primarily effected by astrocytes and microglia. Each cell-type performs many functions in supporting healthy, uninjured neural tissue, and each is also 'activated' by injury related mechanisms that result in changes in morphology, expression profile, and function. Tissue response has also been shown to be greater in situation where the electrodes are anchored through the subject's skull; the tethering forces aggravate the injury caused by the electrode's insertion and sustain the tissue response.
One function taken on by microglia when activated is to cluster around foreign bodies and degrade them enzymatically. It has been proposed that when the foreign body cannot be degraded, as in the case of implanted electrodes whose material composition is resistant to such enzymatic dissolution, this 'frustrated phagocytosis' contributes to the failure of recordings, releasing necrotic substances into the immediate vicinity and contributing to cell death around the electrode.
Activated astrocytes form the major component of the encapsulating tissue that forms around implanted electrodes. "Current theories hold that glial encapsulation, i.e. gliosis, insulates the electrode from nearby neurons, thereby hindering diffusion and increasing impedance, extends the distance between the electrode and its nearest target neurons, or creates an inhibitory environment for neurite extension, thus repelling regenerating neural processes away from recording sites". Either activated astrocytes or buildup of cellular debris from cell death around the electrode would act to insulate the recording sites from other, active neurons. Even very small increases in the separation between the electrode and local nerve population can insulate the electrode completely, as electrodes must be within 100 μm to get a signal.
Another recent study addresses the problem of the tissue response. Michigan-type electrodes (see article for detailed dimensions) were surgically inserted into the brains of Adult male Fischer 344 rats; a control population was treated with the same surgical procedures, but the electrode was implanted and immediately removed so that a comparison could be made between tissue response to acute injury and chronic presence. Animal subjects were sacrificed at 2 and 4 weeks after implantation to quantify the tissue response with histological and immunostaining techniques. Samples were stained for ED1 and GFAP presence. ED1+ reading is indicative of the presence of macrophages, and was observed in a densely packed region within approximately 50 μm of the electrode surface. ED1+ cells were present at both 2 and 4 weeks after implantation, with no significant difference between the time points. Presence of GFAP indicates presence of reactive astrocytes, and was seen at 2 and 4 weeks after implantation, extending more than 500 μm from the electrode surface. Stab controls showed signs of inflammation and reactive gliosis as well, however signals were significantly lower in intensity than those found in chronic test subjects, and diminished noticeably from 2 weeks to 4 weeks. This is strong evidence that glial scarring and the encapsulation, and eventual isolation, of implanted microelectrodes is primarily a result of chronic implantation, and not the acute injury.
Another recent study addressing the impact of chronically implanted electrodes points that tungsten-coated electrodes seem to be well tolerated by the nervous tissue, inducing a small and circumscribed inflammatory response only in the vicinity of the implant, associated with a small cell death .
Techniques for combating long-term failure of electrodes are understandably focused on disarming the foreign body response. This can most obviously be achieved by improving the biocompatibility of the electrode itself, thus reducing the tissue's perception of the electrode as a foreign substance. As a result, much of the research towards alleviating the tissue response is focused on improved biocompatibility.
It is difficult to effectively evaluate progress towards improved electrode biocompatibility because of the variety of research in this field.
This section loosely categorizes different approaches to improving biocompatibility seen in the literature. Descriptions of the research are limited to a brief summary of the theory and technique, not the results, which are presented in detail in the original publications. Thus far, no technique has achieved results drastic and sweeping enough to change the fact of the encapsulation response.
Research focusing on bioactive coatings to alleviate the tissue response is conducted primarily on silicon-based electrodes. Techniques include the following:
Another body of research dedicated to improving the biocompatibility of electrodes focuses on functionalizing the electrode surface with relevant protein sequences. Studies have demonstrated that surfaces functionalized with sequences taken from adhesive peptides will decrease cellular motility and support higher neuronal populations. It has also been shown that peptides can be selected to specifically support neuronal growth or glial growth, and that peptides can be deposited in patterns to guide cellular outgrowth. If populations of neurons can be induced to grow onto inserted electrodes, electrode failure should be minimized.
Kennedy's research details the use of a glass cone electrode which contains a microwire built inside of it. The microwire is used for recording, and the cone is filled with neurotrophic substances or neural tissue in order to promote growth of local neurons into the electrode to allow for recording. This approach overcomes tissue response by encouraging neurons to grow closer to recording surface.
Some notable success has also been made in developing microfluid delivery mechanisms that could ostensibly deliver targeted pharmacological agents to electrode implantation sites to alleviate the tissue response.
Just as in other fields, some effort is devoted explicitly to the development of standardized research tools. The goal of these tools is to provide a powerful, objective way of analyzing the failure of chronic neural electrodes in order to improve the reliability of the technology.
One such effort describes the development of an in vitro model to study the tissue response phenomenon. Midbrains are surgically removed from day 14 Fischer 344 rats and grown in culture to create a confluent layer of neurons, microglia, and astrocytes. This confluent layer can be used to study the foreign body response by scrape-injury or depositing electrode microwires on the monolayer, fixing the culture at defined time points after insertion/injury and studying tissue response with histological methods.
Another research tool is a numerical model of the mechanical electrode-tissue interface. The goal of this model is not to detail the electrical or chemical characteristics of the interface, but the mechanical ones created by electrode-tissue adhesion, tethering forces, and strain mismatch. This model can be used to predict forces generated at the interface by electrodes of different material stiffnesses or geometries.
For studies requiring a massive quantity of identical electrodes, a bench-top technique has been demonstrated in the literature to use a silicon shape as a master to produce multiple copies out of polymeric materials via a PDMS intermediate. This is exceptionally useful for material studies or for labs who need a high volume of electrodes but cannot afford to buy them all.
Electrophysiology is the branch of physiology that studies the electrical properties of biological cells and tissues. It involves measurements of voltage changes or electric current or manipulations on a wide variety of scales from single ion channel proteins to whole organs like the heart. In neuroscience, it includes measurements of the electrical activity of neurons, and, in particular, action potential activity. Recordings of large-scale electric signals from the nervous system, such as electroencephalography, may also be referred to as electrophysiological recordings. They are useful for electrodiagnosis and monitoring.
A brain–computer interface (BCI), sometimes called a brain–machine interface (BMI), is a direct communication pathway between the brain's electrical activity and an external device, most commonly a computer or robotic limb. BCIs are often directed at researching, mapping, assisting, augmenting, or repairing human cognitive or sensory-motor functions. They are often conceptualized as a human–machine interface that skips the intermediary component of the physical movement of body parts, although they also raise the possibility of the erasure of the discreteness of brain and machine. Implementations of BCIs range from non-invasive and partially invasive to invasive, based on how close electrodes get to brain tissue.
Astrogliosis is an abnormal increase in the number of astrocytes due to the destruction of nearby neurons from central nervous system (CNS) trauma, infection, ischemia, stroke, autoimmune responses or neurodegenerative disease. In healthy neural tissue, astrocytes play critical roles in energy provision, regulation of blood flow, homeostasis of extracellular fluid, homeostasis of ions and transmitters, regulation of synapse function and synaptic remodeling. Astrogliosis changes the molecular expression and morphology of astrocytes, in response to infection for example, in severe cases causing glial scar formation that may inhibit axon regeneration.
Brain implants, often referred to as neural implants, are technological devices that connect directly to a biological subject's brain – usually placed on the surface of the brain, or attached to the brain's cortex. A common purpose of modern brain implants and the focus of much current research is establishing a biomedical prosthesis circumventing areas in the brain that have become dysfunctional after a stroke or other head injuries. This includes sensory substitution, e.g., in vision. Other brain implants are used in animal experiments simply to record brain activity for scientific reasons. Some brain implants involve creating interfaces between neural systems and computer chips. This work is part of a wider research field called brain–computer interfaces.
Neuroprosthetics is a discipline related to neuroscience and biomedical engineering concerned with developing neural prostheses. They are sometimes contrasted with a brain–computer interface, which connects the brain to a computer rather than a device meant to replace missing biological functionality.
Neural engineering is a discipline within biomedical engineering that uses engineering techniques to understand, repair, replace, or enhance neural systems. Neural engineers are uniquely qualified to solve design problems at the interface of living neural tissue and non-living constructs.
In neuroscience, single-unit recordings provide a method of measuring the electro-physiological responses of a single neuron using a microelectrode system. When a neuron generates an action potential, the signal propagates down the neuron as a current which flows in and out of the cell through excitable membrane regions in the soma and axon. A microelectrode is inserted into the brain, where it can record the rate of change in voltage with respect to time. These microelectrodes must be fine-tipped, impedance matching; they are primarily glass micro-pipettes, metal microelectrodes made of platinum, tungsten, iridium or even iridium oxide. Microelectrodes can be carefully placed close to the cell membrane, allowing the ability to record extracellularly.
Electrocorticography (ECoG), a type of intracranial electroencephalography (iEEG), is a type of electrophysiological monitoring that uses electrodes placed directly on the exposed surface of the brain to record electrical activity from the cerebral cortex. In contrast, conventional electroencephalography (EEG) electrodes monitor this activity from outside the skull. ECoG may be performed either in the operating room during surgery or outside of surgery. Because a craniotomy is required to implant the electrode grid, ECoG is an invasive procedure.
A cultured neuronal network is a cell culture of neurons that is used as a model to study the central nervous system, especially the brain. Often, cultured neuronal networks are connected to an input/output device such as a multi-electrode array (MEA), thus allowing two-way communication between the researcher and the network. This model has proved to be an invaluable tool to scientists studying the underlying principles behind neuronal learning, memory, plasticity, connectivity, and information processing.
A nerve guidance conduit is an artificial means of guiding axonal regrowth to facilitate nerve regeneration and is one of several clinical treatments for nerve injuries. When direct suturing of the two stumps of a severed nerve cannot be accomplished without tension, the standard clinical treatment for peripheral nerve injuries is autologous nerve grafting. Due to the limited availability of donor tissue and functional recovery in autologous nerve grafting, neural tissue engineering research has focused on the development of bioartificial nerve guidance conduits as an alternative treatment, especially for large defects. Similar techniques are also being explored for nerve repair in the spinal cord but nerve regeneration in the central nervous system poses a greater challenge because its axons do not regenerate appreciably in their native environment.
Microelectrode arrays (MEAs) are devices that contain multiple microelectrodes through which neural signals are obtained or delivered, essentially serving as neural interfaces that connect neurons to electronic circuitry. There are two general classes of MEAs: implantable MEAs, used in vivo, and non-implantable MEAs, used in vitro.
Neurostimulation is the purposeful modulation of the nervous system's activity using invasive or non-invasive means. Neurostimulation usually refers to the electromagnetic approaches to neuromodulation.
The neurotrophic electrode is an intracortical device designed to read the electrical signals that the brain uses to process information. It consists of a small, hollow glass cone attached to several electrically conductive gold wires. The term neurotrophic means "relating to the nutrition and maintenance of nerve tissue" and the device gets its name from the fact that it is coated with Matrigel and nerve growth factor to encourage the expansion of neurites through its tip. It was invented by neurologist Dr. Philip Kennedy and was successfully implanted for the first time in a human patient in 1996 by neurosurgeon Roy Bakay.
A hippocampus prosthesis is a type of cognitive prosthesis. Prosthetic devices replace normal function of a damaged body part; this can be simply a structural replacement or a rudimentary, functional replacement.
As with any material implanted in the body, it is important to minimize or eliminate foreign body response and maximize effectual integration. Neural implants have the potential to increase the quality of life for patients with such disabilities as Alzheimer's, Parkinson's, epilepsy, depression, and migraines. With the complexity of interfaces between a neural implant and brain tissue, adverse reactions such as fibrous tissue encapsulation that hinder the functionality, occur. Surface modifications to these implants can help improve the tissue-implant interface, increasing the lifetime and effectiveness of the implant.
The Shannon criteria constitute an empirical rule in neural engineering that is used for evaluation of possibility of damage from electrical stimulation to nervous tissue.
Stentrode is a small stent-mounted electrode array permanently implanted into a blood vessel in the brain, without the need for open brain surgery. It is in clinical trials as a brain–computer interface (BCI) for people with paralyzed or missing limbs, who will use their neural signals or thoughts to control external devices, which currently include computer operating systems. The device may ultimately be used to control powered exoskeletons, robotic prosthesis, computers or other devices.
A cortical implant is a subset of neuroprosthetics that is in direct connection with the cerebral cortex of the brain. By directly interfacing with different regions of the cortex, the cortical implant can provide stimulation to an immediate area and provide different benefits, depending on its design and placement. A typical cortical implant is an implantable microelectrode array, which is a small device through which a neural signal can be received or transmitted.
Stéphanie P. Lacour is a French neurotechnologist and full professor holding the Foundation Bertarelli Chair in Neuroprosthetic Technology at the Swiss Federal Institute of Technology in Lausanne (EPFL). Lacour is a pioneer in the field of stretchable electronics and directs a laboratory at EPFL which specializes in the development of Soft BioElectronic Interfaces to enable seamless integration of neuroprosthetic devices into human tissues. Lacour is also a co-founding member and director of the Center for Neuroprosthetics at the EPFL Satellite Campus in Geneva, Switzerland.